For up to date information regarding COVID-19 in South Africa, please visit sacoronavirus.co.za
Research Themes
-
HIV Treatment Outcomes and Guidelines
-
Linkage, Retention and Adherence for HIV Treatment in South Africa
-
Costs, Cost-Effectiveness and Benefits of HIV Care and Treatment
-
Tuberculosis and HIV in South Africa
-
Cost and Budget Modelling
-
Sexual and Reproductive Health
-
Primary Health Care
-
Non-Communicable Diseases
-
Research Capacity Building
Research Programs
-
Evaluations to Inform Decisions using Economics and Epidemiology (EVIDENCE)
-
Indlela: Behavioural Insights for Better Health
-
COVID-19 Response
-
Economic Impact of HIV
-
Innovations Research on AIDS (INROADS)
-
AMBIT: Alternative Models of ART Delivery – Optimizing the Benefits
-
Using routinely collected laboratory data to evaluate South Africa’s national HIV treatment program through a national HIV cohort
-
Journal Articles
Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa
Introduction: Policies for Universal Test & Treat (UTT) and same-day initiation (SDI) of antiretroviral therapy (ART) were instituted in South Africa in September 2016 and 2017 respectively. However, there is limited evidence on whether these changes have improved patient retention after HIV diagnosis.... -
Journal Articles
Adaptation of WHO’s generic tuberculosis patient cost instrument for a longitudinal study in Africa
The WHO developed a generic ‘TB patient cost survey’ tool and a standardized approach to assess the direct and indirect costs of TB incurred by patients and their households, estimate the proportion of patients experiencing catastrophic costs, and measure the impact of interventions to reduce patient costs. While the generic tool is a facility-based cross-sectional ...
-
Journal Articles
Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa
In South Africa, the 15-24-year age group are at an increased risk of HIV infection [1]. In 2017, HIV incidence for young adults between the ages of 15–24 was 1.0% (95% CI 0.86–1.15),
translating to an estimated 88 400 new infections [2, 3]. In the same year, WHO and other UN partners launched the ...
-
Vacancies
STUDY COUNSELLORS (SEVERAL POSITIONS)
The Health Economics and Epidemiology Research Office (HE²RO) of the University of the Witwatersrand, based in Parktown, Johannesburg, is an internationally recognized health research group with a focus on HIV and tuberculosis. HE²RO seeks to build the evidence base to improve the health policies and programmes in South Africa and the region. We collaborate on ...
-
Vacancies
Senior/Principal Researcher – Health Economics
We seek a dynamic, enthusiastic, and self-motivated quantitative senior researcher to be part of our health economics research and implementation science portfolio. This portfolio focuses on the costs, cost-effectiveness, and benefits of healthcare interventions, health financing and health systems, and other priority public health challenges, with opportunities for both primary data collection and mathematical modeling. ...
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.
News
-
HE2RO contributes to NDOH’s Covid-19 modelling
We are pleased to announce that we are now able to share the reports on the projections of the National Covid-19 Epi Model to which...
-
HE2RO has been awarded a new 5-year Co-operative Agreement from USAID
HE2RO has been awarded a new 5-year Co-operative Agreement from USAID. This new program, the HIV/AIDS Economics and Research Activity, called EVIDENCE will run...
-
HE2RO is now a HBNU approved Fogarty Global Health Training Program Site
HE2RO has been approved to be a HBNU site for the Fogarty Global Health Training Program. The program provides opportunities to generate a new...
